Status:
UNKNOWN
Assessment of SARS-CoV-2 Effect on Post-traumatic Stress of Patients Hospitalized in Intensive Care Unit
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Intensive Care Unit
SARS-CoV2
Eligibility:
All Genders
18+ years
Brief Summary
Patients admitted to the intensive care unit develop psychiatric disorders, such as anxiety, depression or post-traumatic stress disorder, which can be prolonged. During the COVID crisis, the presenc...
Detailed Description
The stay in the ICU is a complex and often traumatic experience for patients. Patients often develop psychiatric disorders such as anxiety, depression or post-traumatic stress disorder after an ICU st...
Eligibility Criteria
Inclusion
- Major patients (above 18 years old)
- Admitted in intensive care unit
- Hospitalized more than 2 days (48 hours)
- Between 01/01/2020 and 06/30/2020
- Whether SARS-CoV-2 positive or negative
Exclusion
- Minor patient
- Protected major (under safeguardship, curatorship or guardianship)
- Patient opposition
Key Trial Info
Start Date :
April 27 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 27 2021
Estimated Enrollment :
264 Patients enrolled
Trial Details
Trial ID
NCT04872049
Start Date
April 27 2021
End Date
October 27 2021
Last Update
May 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GH Pitié Salpêtrière - Charles Foix
Paris, Île-de-France Region, France, 75013